Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir UseMelissa Crawford, Nassrin Payvandi, Jean van Wyk et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2019Cited by 12
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studiesMounir Ait‐Khaled, Jean van Wyk, Juan Sierra Madero et al.|HIV Research & Clinical Practice|2021Cited by 11
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studiesSharon Walmsley, Mounir Ait‐Khaled, Richard Grove et al.|AIDS Research and Therapy|2024Cited by 11
1024. Impact of Treatment Adherence on Efficacy of DTG/3TC and DTG + TDF/FTC: Pooled Analysis of the GEMINI 1 and 2 Clinical TrialsMounir Ait‐Khaled, Hung‐Chin Tsai, Choy Man et al.|Open Forum Infectious Diseases|2020Cited by 1